Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003;83(2):68–78; discussion 78–79. ArticlePubMedGoogle Scholar Ota DM. Laparoscopic resection for colon cancer: a favorable...
In addition to people receiving no treatment or placebo, for each diabetes medication of interest, people using one or more other diabetes medications were considered to be eligible as controls. Control groups were from population-based and hospital settings in observational studies and in RCTs, ...
Somatic mutations in cancer genomes are caused by multiple mutational processes, each of which generates a characteristic mutational signature1. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium2 of the International Cancer Genome Consortium (ICGC) and The Cancer Genome At...
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030-4009, USA Yuan Li, Jaffer A. Ajani & Shumei Song Department of Surgical Oncology and General Surgery, First Hospital of China Medical University, Shenyang,...
Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer (BC) with a poor prognosis. Current treatment options are limited to surgery, adjuvant chemotherapy and radiotherapy; however, a proportion of patients have missed the su
Beth Israel Deaconess Medical Center, Boston, MA; The University of Texas MD Anderson Cancer Center, Houston, TX; Yale Cancer Center, New Haven, CT; Rutgers Cancer Institute of New Jersey, Rutgers, NJ; Massachusetts General Hospital, Boston, MA; University of Colorado Cancer Center, Denver, CO...
Tissue samples were soon preserved in -80 ℃. None of these patients received any radiotherapy or preoperative chemotherapy. This clinical study was approved by the ethical review board of the Meizhou People's Hospital and the ethical guidelines of Helsinki. All patients who enrolled in this study...
Dana-Farber Cancer Institute, Boston, MA; University of North Carolina at Chapel Hill, Chapel Hill, NC; University of California at San Francisco, San Francisco, CA; Johns Hopkins School of Medicine, Baltimore, MD; Massachusetts General Hospital, Boston, MA; University of Michigan, Ann Arbor, ...
Brigham and Women’s Hospital, Boston, MA, USA Sapna Syngal Dana Farber Cancer Institute, Boston, MA, USA Sapna Syngal Harvard Medical School, Boston, MA, USA Sapna Syngal Center for Advanced Biotechnology and Medicine, Rutgers University, Piscataway, NJ, USA Martin J. Blaser Lee Kong Chian...
Department of Medicine, Brigham and Women’s Hospital, Boston, MA, 02115, USA Maša Alečković, Carlos R. Gil Del Alcazar, Pengze Yan, Lina Ding, Ernesto Rojas Jimenez, Anushree C. Gulvady, Pierre Foidart, Marco Seehawer & Kornelia Polyak Department of Medicine, Harvard Medical School...